ABSTRACT Nutmeg (seed of Myristica fragrans [MF]) is one of the most commonly used spices in the world and also a well-known herb for the treatment of various intestinal diseases, including colitis in traditional Korean medicine. The purpose of the current study was to investigate whether water extract of MF (MFE) can protect against dextran sulfate sodium (DSS) induced colitis in a mouse model. Colitis was induced by 5% DSS in balb/c mice. MFE (100, 300 or 1000 mg/kg) was orally administered to the mice twice a day for 7 days. Body weight, colon length, clinical score, and histological score were assessed to determine the effects on colitis. Proinflammatory cytokines (interferon-c, tumor necrosis factor-a, interleukin [IL]-1b, and IL-6) were measured to investigate the mechanisms of action. MFE dose dependently inhibited the colon shortening and histological damage to the colon. However, it did not prevent weight loss. MFE also inhibited proinflammatory cytokines. The current results suggest that MFE ameliorates DSS-induced colitis in mice by inhibiting inflammatory cytokines. Further investigation, including the exact mechanisms is needed.
D
ue to the limitations of various conventional therapies, there is still a need for new alternative treatments for inflammatory bowel disease (IBD), and natural products, including herbal medicine are being extensively studied. 1 However, many natural products, including dietary supplements and herbal medicines remain to be studied.
The seed of Myristica fragrans (MF), distributed in tropical Asia, has been used for several intestinal symptoms, including vomiting and diarrhea. 2 Despite various reports about the bioactivities of MF, including anti-inflammatory and antidiarrheal effects, 3, 4 there is no scientific evidence supporting its effect on IBD. Thus, we investigated the effects of water extract of MF (MFE) in a mouse colitis model. In the current study, we orally administered MFE to mice with dextran sulfate sodium (DSS) induced colitis, which is one of the popular colitis models, 5 and investigated its protective effects.
Seeds of MF (390 g) were purchased from Kyung Hee Hanyak Co. (Seoul, Korea), and extracted by boiling in water at 100°C for 2 h. MFE (yield = 6.83%) was obtained by evaporating and freeze drying. MF (PS005) and MFE (PSE006) were deposited in the Department of Herbal Pharmacology, Kyung Hee University. We analyzed MFE using standards, myristicin (Sigma, St. Louis, MO, USA) and safrol (Sigma) by HPLC, and found that the retention time was 16.7 and 17.3 min, respectively (Fig. 1A) . The extract was standardized to contain 0.13% myristicin and 0.20% safrol.
Seven-week-old male balb/c mice (20-24 g; Daehan Bio Link, Seoul, Korea) were housed at 20-22°C and in 40-60% humidity under a 12 h light/dark cycle, and provided food and water ad libitum. All procedures were approved and conducted according to animal welfare guidelines of Kyung Hee University Institutional Animal Care and Use Committee [KHUASP(SE)-09-036]. Colitis was induced by DSS as previously described. 6 Briefly, the mice were provided with drinking water containing 5% DSS (MP Biomedicals, Tokyo, Japan) ad libitum for 7 days. We administered MFE (100, 300, and 1000 mg/kg, p.o.) or same volume (5 mL/kg) of distilled water twice a day for 7 days. Body weight was measured daily from day 0 to 7. The colon was isolated immediately after the last weight check and colon length was measured by using a vernier caliper (Mitutoyo, Kawasaki, Japan). Clinical score was measured by a modified method previously reported. 7 Briefly, spontaneous behavior and posture, coat and piloerection and cleaning of perianal region were evaluated for clinical score. Scores were evaluated using a 5-point Likert scale and summed for data. The colons were fixed in 10% buffered formalin and the sections (5 lm in thickness), obtained from the paraffin blocks, were stained with hematoxylin and eosin. In a blind fashion, we analyzed the histological damage according to inflammatory cell infiltration and ulceration, and histological score was obtained by averaging all scores. 8 Isolated colons were snap frozen and stored at -70°C. The mucosa was scraped from the colon. Next, 10 mg mucosa was dissolved in tripledetergent lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% sodium dodecyl sulfate, 1% NP-40, 0.02% sodium azide, 0.5% sodium deoxycholate and 1 mM phenylmethylsulfonyl fluoride) and homogenized. Interferon (IFN)-c, tumor necrosis factor (TNF)-a, interleukin (IL)-1b, and IL-6 in the mucosa samples were analyzed according to the manufacturer's manual of biometric multiplex cytokine assay (Millipore, Billerica, MA, USA).
All results were expressed as mean -SEM and analyzed using one-way ANOVA followed by Dunnett's test (GraphPad Prism version 5.01; GraphPad Software, San Diego, CA, USA) for comparative analysis with control group. P-value < .05 was regarded as statistically significant.
Body weight in the control group continuously decreased. MFE treatment did not show any effects on body weight (Fig. 1B) . While control group showed colon shortening compared with the normal group, the MFE-treated groups exhibited less shortened and edematous colons with less damage to the cecums than in the control group (Fig. 1C) . MFE treatment significantly inhibited the colon shortening in a dose-dependent manner (Fig. 1D) . The clinical score of the control group began to decrease rapidly from day 3. MFE-treated groups had better clinical scores from day 3 to 5 compared to the control group. However, it did not show the effects from day 6 (Fig. 1C) . MFE-treated groups showed relatively intact surface epithelia and cryptal glands, whereas the control group showed disruptions of the cryptal glands and infiltration of inflammatory cells (Fig. 2A) . MFE showed dose-dependent protective effects against histologically evaluated damage ( Fig. 2A) . MFE-treated groups significantly inhibited IFN-c, TNF-a, IL-1b, and IL-6 productions in colon mucosa (Fig. 2B) .
FIG. 1.
The representative chromatograms of MFE (A) and the effects of MFE on body weight (B), clinical score (C), and colon length (D) in a DSS-induced mice colitis model. Photos of isolated colon show typical morphologies and length of each group. The normal group was not treated with DSS or MFE and the control group was treated with DSS and distilled water. Data are expressed as mean -SEM, n = 8. *P < .05, **P < .01 and ***P < .001 compared to control group. MFE, extract of Myristica fragrans; DSS, dextran sulfate sodium.
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In the current study, oral administration of MFE showed dose-dependent protective effects against colon shortening, clinical symptoms,, and histological observed damage in DSS-induced colitis model. MFE also downregulated mucosal inflammatory cytokines.
MFE treatment showed dose-dependent protection against colon shortening. DSS induces various gastrointestinal or systemic symptoms. Among them, colon shortening is the most representative finding, which is known to be caused by inflammation-induced structural changes, including ulceration and erosion of the colon mucosa, finally leading to colon shortening. 6, 8, 9 MFE treatment improved the histological score that reflects cryptal damages, and the severity and extent of inflammation. 8 DSS is known to induce cryptal depletion, epithelial damage, ulceration of mucosal layer, inflammatory cell infiltration, muscle thickening, and edema. 8 Thus, the protective effects of MFE might be caused by inhibiting inflammation-derived structural changes. MFE also improved clinical scores at day 3, 4, and 5, but not day 6 and 7. Clinical score is known to reflect the state and symptoms of human diseases. 10 Thus, it could suggest that MFE improves the symptoms in colitis patients. However, ineffectiveness of clinical scores at day 6 and 7 might be originated from severe damages of intestine.
MFE did not inhibit weight loss in DSS-induced colitis. DSS is known to influence on whole body system by penetration through intestinal mucosa and distribution to other organs, including liver and kidney, besides colon. 8, 9 Thus, the evidence suggests that the effects of MFE might be due to direct anti-inflammatory effects on colon.
In the current study, DSS treatment up-regulated proinflammatory cytokines in inflamed mucosa. 11 MFE inhibited representative proinflammatory cytokines (IFN-c, TNF-a, IL-1b, and IL-6) in the colon mucosa. Deleterious effects of proinflammatory cytokines in IBD have been well documented and cytokine inhibition could be the most important target for mechanistic studies. 11 Thus, the inhibitory -6) . Data are expressed as mean -SEM, n = 8. *P < .05, **P < .01 and ***P < .001 compared to control group. IFN, interferon; TNF, tumor necrosis factor; IL, interleukin.
effects of MFE on cytokines could be the mechanisms of action.
In conclusion, MFE showed protective effects against DSS-induced colitis by inhibiting proinflammatory cytokines in the colon mucosa. This suggests the potential for using MFE in a preventive application against intestinal inflammation. Further investigation, including the exact mechanism is needed.
